| Autor: |
Hughes K; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.; South London and Maudsley NHS Foundation Trust, London, United Kingdom., Jacobson CEH; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Lavelle G; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom., Carr E; Department of Biostatistics and Health Informatics, King's College London, London, United Kingdom., Henley SMD; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. |
| Abstrakt: |
Purpose: There is limited research on the psychological impact of cancer for teenagers and young adults (TYAs) and the role of protective factors such as resilience. This study investigated associations between resilience and psychosocial outcomes in this group. Methods: Data were collected from TYAs (aged 16-24) who attended the TYA cancer clinic at Guy's Hospital between 2013 and 2021. Participants ( N = 63) completed psychosocial questionnaires within 4 weeks of their treatment start date ( T 1 ) and again between 9 and 15 months later ( T 2 ). We used separate multivariable linear regression models to analyze associations of resilience (Brief Resilience Questionnaire) with outcomes measured at T 2, including symptoms of depression (Patient Health Questionnaire [PHQ]-9), anxiety (Generalized Anxiety Disorder [GAD]-7), and subjective quality of life. Models were adjusted for age, gender, ethnicity, and T 1 outcome assessments. Results: Higher resilience at T 1 was associated with increased anxiety ( β = 1.68; bootstrapped confidence interval [95% CI -0.28 to 3.19]), depression ( β = 1.24; [-0.85 to 2.90]), and quality of life (5.76; [-0.88 to 15.60]). In contrast, an increase in resilience over time was associated with decreases in the same period in anxiety ( β = -3.16; [-5.22 to -1.47]) and depression ( β = -2.36, [-4.41 to -0.58]), and an increase in quality of life ( β = 9.82, [-0.24 to 21.13]). Conclusion: Increases in resilience during cancer treatment were associated with reduced symptoms of depression and anxiety in TYAs. We discuss factors likely to influence these outcomes, the implications for psychosocial interventions in this population, and identify further research to explore the impact of other factors such as diagnosis and treatment type. |
